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Accumulating evidence suggests that the hematopoietic stem cell population is 
heterogeneous in terms of the probability that at its next division a cell will give 
rise to either other stem cells or cells with restricted developmental potential (1- 
5). It has been proposed (6, 7) that the factor governing the choice is the length 
of the mitotic history of that stem cell. The fewer past divisions, the more likely 
it is to self-replicate; conversely, a  long mitotic history would be associated with 
a  higher  probability  of forming  cells  committed  to  one  or  another  of the 
developmental pathways culminating in functional blood cells. Stem cells more 
likely to self-replicate are generally thought of as being more primitive. 
Stem  cells  surviving  a  single  injection  of 5-fluorouracil  (FU) 1 or  multiple 
injections of hydroxyurea (HU), according to this criterion and others, are on 
average more primitive than the normal, untreated stem cell population (4-8). 
Evidence supporting  this  conclusion comes from several studies including the 
following: (a) Transplanted marrow from HU- or FU-treated mice gave rise to 
individual spleen colonies containing more spleen colony-forming cells (CFU-S) 
and more granulocyte/macrophage CFU (CFU-GM) (primitive granulocyte-mac- 
rophage precursors) than colonies resulting from normal marrow transplants (6, 
7); (b) 5-fluorouracil-treated marrow had a  greater capacity than did untreated 
marrow to restore the CFU-GM population in spleens and marrows of irradiated 
hosts and to restore megakaryocytopoiesis in these organs (4, 9); (c) in competitive 
repopulation studies normal marrow and HU-treated marrow cells were mixed 
and transplanted into irradiated mice (8). One of the two marrow donors bore a 
chromosome marker allowing the derivation of mitotic figures in bone marrow 
or  spleen  cells  in  the  host  to  be  determined.  The  HU-treated cells  outgrew 
normal cells even when they were a numerical minority in the transplant. 
Hodgson and Bradley (4) found that CFU-S from FU-treated mice followed a 
temporally different growth pattern in the spleens of irradiated hosts than CFU- 
S  from normal  donors.  Although the cellular composition  of spleen  colonies 
formed by normal marrow cells has been shown to change with time (10-12), 
the number of colonies remained nearly constant between 8 and 14 d (4, 5). In 
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contrast,  spleen  colonies derived  from  FU-treated  mice steadily increased  in 
number during this period.  The usual 8- or 9-d growth period before spleen 
colonies are counted would, therefore, seriously underestimate the number of 
CFU-S in FU-treated marrow, but not those in normal marrow. One explanation 
for the delay in spleen colony growth caused by FU-treated cells is that primitive 
stem ceils surviving FU are unable to directly initiate colony growth. Rather, the 
population undergoes developmental maturation, giving rise to a cohort of cells 
capable of spleen colonization and growth. It is this series of requisite develop- 
mental steps  that could account for the  delay in  colony growth.  We present 
evidence that this explanation is correct and, moreover, that the locus of at least 
part of developmental maturation of stem cells from FU-treated mice occurs in 
the bone marrow of the hosts. 
Materials and Methods 
Mice.  B6D2F1 (C57BL/6  ~ × DBA/2 d)F1 mice 2-4 mo old and weighing 20-24 g 
were used throughout these studies. They were bred and housed in our specific pathogen- 
free animal facility. 
Spleen Colony Assay.  A single-ceU suspension was injected  in  0.5  ml of 90%  alpha- 
minimum  essential  medium  (MEM) buffered  with  morpholinopropane  sulfonic  acid 
(MOPS), 10% fetal calf serum. Cells were injected intravenously into a lateral tail vein of 
lethally irradiated (9.5 Gy) hosts. Spleens were harvested 8-14 d after irradiation and cell 
injection. Cells were injected within 90 rain of  irradiation of  the host. Macroscopic colonies 
were counted on the surfaces of Bouins'-fixed spleens. 
Irradiation.  A lethal  dose (9.5 Gy) of gamma radiation  was delivered  from a  xS~Cs 
source at a dose rate of 0.92 Gy/min. 
Treatment with Drugs.  HU and FU were obtained from the National Cancer Institute, 
Bethesda, MD. HU and FU were injected intravenously at the specified doses. Control 
mice in each experiment were injected with the drug vehicle. 
Burst Assay.  Erythroid burst-forming  units (BFU-E) were assayed as previously de- 
scribed (13) in alpha medium containing  (in final concentrations)  0.8% methylcellulose 
(Methocel A4M Premium; Dow Chemical Co., Midland, MI), 30% fetal calf serum (Irvine 
Serum Co., Irvine, CA), 1% deionized bovine serum albumin (A-4503; Sigma Chemical 
Co.,  St.  Louis,  MO), 10  -4  M  2-mercaptoethanol  (Sigma Chemical Co.), 2.5  U/ml of 
erythropoietin (Toyobo,  New York), and 25  ~l/ml of medium conditioned for 5 d by 
pokeweed  mitogen-stimulated  spleen  cells (14). Benzidine-positive bursts  (15) were 
counted on day 8 and in another set of 35-mm dishes (5221-R;  Lux Scientific, Inc., 
Thousand Oaks, CA) on day 14. 
89Sr-treated Hosts.  Strontium-89  chloride in 1.5 M HC1 (Oak Ridge National Labora- 
tory, Oak Ridge, TN) was neutralized  and injected intravenously at a concentration of 
2.0 #Ci/gm of body weight. 7 d later they were lethally (9.5 Gy) irradiated. 
Results 
Effects of FU on CFU-S In  Vivo: Time Study of Spleen  Colony Development.  The 
data in Fig. 1 show that whereas the number of spleen colonies caused by normal 
marrow  did  not  change significantly between days 8  and  14,  spleen  colonies 
increased 67-fold when marrow cells from mice given 3 mg of FU 1 d previously 
(1FU marrow) were transplanted. Thus when FU toxicity to CFU-S was assessed 
using an 8-d assay, the surviving fraction was -0.007; in a 14-d assay the surviving 
fraction of CFU-S in the same FU-treated marrow was 0.5. 
Recovery of CFU-S After FU.  From pilot studies we knew that femoral marrow 
cell counts recovered to nearly normal levels -  10 d after an injection of 3 mg of VAN  ZANT  681 
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FIGURE  1.  Temporal pattern of spleen colony growth caused by normal and FU-treated 
marrow cells. The following cell numbers were injected into lethally irradiated (9.5 Gy) hosts: 
3 × 104 normal marrow cells; 9.4 × l0  s 1FU marrow cells for days 10, 12, and 14 of spleen 
harvest; 2.8 ×  106 for the day 8 point.  1FU marrow was pooled from femurs of five mice 
injected 1 d previously with 3 nag of FU. Each represents the mean _  1 standard deviation of 
10 spleens. 
FU;  therefore,  we  set  up an  experiment to  temporally study  CFU-S  numbers 
and the ratio of day  14/day 8  spleen colony counts, what I  will call the atavism 
index (AI), after FU treatment. The results in Table I  show that as the number 
of CFU-S in the marrow recovered after FU, the AI of these CFU-S decreased 
until, by day 7,  the AI  was near the value of 1.3  found in this experiment for 
untreated  normal  marrow.  The  most  dramatic  change  in  the  AI  occurred 
between days 2  and 3  when it declined from ~21  to 9; from day 3 onward the 
change was relatively gradual.  The small increase in AI between days 9 and  11 
is probably not significant; in other experiments we have found that after 12 d 
the AI is always between  1 and 2. 
Frequency of CFU-S and BFU-E in Marrow after FU.  A  further finding of the 
temporal study, not readily apparent in Table I, is that the frequency of CFU-S 
in  marrow  increased  to supranormal  levels during  recovery from  FU.  This is 
graphically illustrated in Fig.  2, where normal, untreated marrow is contrasted 
with marrow 7 d after FU treatment (7FU marrow). In this experiment we found 
a 4-10-fold increase in the frequency of CFU-S in 7FU marrow when compared 
with  normal  marrow,  depending  on whether  8-  or  14-d  spleen colonies were 
compared  (Fig.  2A).  It  should  be  noted  that  7FU  marrow,  like  the  normal 
marrow,  had  an  AI  close  to  unity.  We  also  compared the-frequencies of the 
primitive erythroid precursor,  BFU-E,  in these  marrows.  These results in  Fig. 682  PRIMITIVE  HEMATOPOIETIC  CELLS  SPARED  BY  5-FLUOROURACIL 
TABLE  I 
CFU-S Numbers and Atavism Index After FU In Vivo 
Day 8  Day 14 
Cells per 
Days  femur (X  Fraction of  Fraction of  Atavism 
after FU  10  -6)  femur in-  Colonies  femur in-  Colonies  index 
jected  jected 
0  17.2  0.0025  15.3 +  3.1  0.0025  20.1  4- 4.2  1.3 
1  5.7  0.15  2.1  +  0.7  0.01  3.3 4- 0.8  24 
2  5.9  0.12  6.3+  1.2  0.01  11.2---2.0  21 
3  4.6  0.10  21.3 +  3.3  0.01  19.0 4- 5.9  8.9 
4  5.0  0.02  3.5 4- 1.7  0.01  9.2 --- 2,5  5.3 
5  6.3  0.01  7.6 +  2.9  0.005  20.4 +  3.4  5.4 
7  7.6  0.002  15.9 -  4.7  0.002  28.8 -4- 4.4  1,8 
9  12.4  0.0025  21.6 -+ 4.9  0.0025  33.7 4- 3.8  1.6 
11  16.0  0.0025  13.4 4- 2.5  0.0025  31.5 4- 4.6  2.4 
At each of the time points, groups of three to six mice injected with FU (3 mg, i.v.) were sacrificed 
and  femoral  marrow  was  pooled.  The  designated  femoral  fractions  were  injected  into  groups of 
lethally irradiated (9.5 Gy) mice. Spleen colonies were counted on days 8 and 14. Colony counts are 
presented as the means -!-_ 1 standard deviation of 10-12 spleens per point. 
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FIGURE  2.  Growth of CFU-S and BFU-E from marrow 7  d  after FU injection.  For CFU-S 
determinations,  1  x  10  4 7FU  marrow cells were  injected;  3  x  10  4 normal cells were  used. 
Burst counts were made in dishes plated with 1 ×  10  5 cells. Spleen colony counts are the mean 
+  1 standard deviation of 10 spleens; four replicate burst cultures were used. 
2B show that unlike CFU-S,  the frequency of BFU-E was not increased above 
normal values in 7FU marrow. This was true for bursts counted on day 8 and 
those larger, more heterogeneous and less frequent bursts found after 14 d  of 
culture (14). 
Effects  of FU on CFU-S In Vitro: Concentration Study.  Table II shows that FU in 
vitro caused  the  same  qualitative and  quantitative changes  in  marrow CFU-S 
that we found in vivo: in 2 h, FU killed CFU-S in a dose-dependent manner and 
the AI of the survivors increased dramatically. In this experiment, exposure of 
CFU-S to a  50  /~g/ml concentration of FU,  resulted in a  surviving population 
with an  AI  of 112.  These results argue that  the effects of FU  on  CFU-S are 
direct and  rapid;  metabolism of the  drug  in  vivo is  not required nor are  the 
effects of FU mediated by other tissues.  In studies not reported here we have 
shown that after as little as 15 min, 70% of cells forming 8-d colonies were killed 
and surviving CFU-S were characterized by an AI of ~3. VAN  ZANT 
TABLE  II 
Effect of FU Concentration on CFU-S In Vitro 
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Day 8  Day 14 
FU  Cells  in-  Atavism 
concen-  jected  Colonies  per 105  Surviving  Colonies  per  Surviving  index  105 cells in-  tration  (× 10  -4)  cells injected  fraction  jected  fraction 
ug/ml 
0  3  46.7±6.7  1.0  50.0±6.7  1.0  1.1 
5  4  17.5±5.0  3.8x10  -~  60.4±9.9  1.2  3.5 
10  10  2.3±1.1  4.9×10 -2  14.3±2.6  2.9x10  -~  6.2 
25  20  0.50±0.2  1.1xl0  -~  4.5±1.0  9.0x10  -2  9.0 
50  40  0.025±0.0075  5.4×10 -4  2.8±1.1  5.6×10 -~  112 
Marrow cells (5 x  106/ml) incubated 2 h in polystyrene tubes with the designated concentration of 
FU in 90% c~-MEM, 10% fetal calf serum at 37°C. The cells were washed twice in fresh medium 
before injection into lethally irradiated  hosts. Spleen colony counts are presented as means +  1 
standard deviation of 10 spleens per group. 
CFU-S Surviving FU Seed in the Marrow Before  Colonizing the Spleen.  Additional 
spleen colonies appearing between days 8 and 14 could arise from cells originally 
seeding in the spleen but not immediately commencing growth, or they could 
form from cells seeding in the marrow and subsequently seeding the spleen. To 
distinguish between these possibilities, we assayed marrow from FU-treated mice 
in  two  sets  of hosts:  normal  and  89Sr-treated.  Strontium-89  is  a  bone-seeking 
beta-emitting  isotope  that  causes  ablation  of marrow  hematopoiesis  by  local 
irradiation.  Splenic  hematopoiesis  is  not  compromised  by  this  treatment;  the 
spleen  in  fact  becomes  the  sole  hematopoietic  organ  in  these  animals  (16).  I 
reasoned that  if CFU-S  from  1FU  marrow  lodged  first in  the  marrow before 
seeding  the  spleen,  such  cells  would  be  killed  by  local  irradiation  within  the 
marrow before they could migrate to and colonize the spleen.  If this were the 
case,  the  number  of day  14  colonies should  be  reduced  in  strontium-treated 
hosts when compared with the same marrow assayed in normal hosts.  If on the 
other  hand,  the  requisite  steps  preceding  spleen  colony growth  occur  in  the 
spleen (or other organs except marrow), the AI should be comparable in normal 
and 89Sr-treated hosts. The results of a  representative experiment in Table III 
show  a  marked  contrast  between  the  AI  obtained  in  the  two  sets  of hosts. 
Fluorouracil-treated marrow,  assayed in  irradiated,  normal  hosts,  as expected, 
had a  high AI (~13);  in irradiated, 89Sr-treated hosts, the same marrow had an 
AI of 1.3, a  value expected for normal marrow. We assayed normal marrow in 
the two sets of hosts to show  that 89Sr  treatment per se did not interfere with 
spleen colony growth. Colony counts at 8 and 14 d were not significantly different 
between the two sets of hosts; the AI was ~ 1 in both cases. Marrow cells harvested 
from strontium-injected mice and assayed in normal hosts contained no CFU-S, 
thus demonstrating the efficacy of 89Sr in causing ablation of marrow hemato- 
poiesis. We obtained quantitatively similar results in two other experiments. 
Effects  of Cell  Number  on  CFU-S  Assay.  In  some  experiments  (Table  I,  for 
example), it was not feasible to assay the same number of cells in both the 8- and 
14-d assay animals. When the AI was numerically large, a marrow inoculum that 
gave a  small number of colonies at 8 d  could result in confluent spleen colonies 684  PRIMITIVE  HEMATOPOIETIC  CELLS  SPARED  BY  5-FLUOROURACIL 
TABLE  III 
Comparison of Spleen Colony Growth in Normal and SgSr-injected Hosts 
Number 
Source of marrow  of cells in- 
cells  jected (x 
10 ~) 
Spleen colonies 
Normal hosts  SgSr-treated hosts 
Atavism Index 
8 d  14 d  8 d  14 d  Atavism Index 
(AI) 
Normal mice  3  11.84- 2.6  11.6 ± 1.9  0.98± OAI*  13.2 4- 1.6  14.5 ± 3.3  1.1 ± 0.21"* 
IFU mice  30  2.9:t:0.9  39.04-7.6  13.44-2.7"  3.84-1.2  4.9±1.0  1.3±0.27"* 
SgSr-treated mice  30  O  O.l 4- 0.3  --  0  0  -- 
No cells  0  0.2 ± 0.3  0  --  O  0.1 ± 0.3  -- 
Marrow cells from groups of at least three of the designated donors were pooled and injected into groups of 10-15  (a) normal, 
irradiated (9.5 Gy) hosts and (b) irradiated hosts that had been injected with SgSr (2.0 ttCi/gm body weight i.v.) 7 d previously. IFU 
marrow is from donors injected I d previously with FU (3 rag, i.v.). SgSr-treated marrow is from donors injected with strontium-89 
7d before  marrow harvest. Groups designated  * differ significantly (P <  0.001) by Student's  t test; groul~s marked  ** are not 
significantly different  (P >  0.05). Spleen colony counts are presented  as means 4-  1 standard  deviation. These data are from a 
representative experiment; qualitatively similar results were obtained in two others. 
TABLE  IV 
Lack of Effect of Added Irradiated Cells on Spleen Colony Formation by CFU-S From Normal 
Marrow and 1FU Marrow 
Cells injected (x  10  -r)  Spleen colonies (4-1 SD) 
Irradi-  Irradi- 
Normal  ated nor-  1FU 
ated  1FU  Day 8  Day 13 




4  --  --  --  15.3 +  3.3  19.3 4-_ 4.1  1.3 
4  10  --  --  17.8 +  2.7  ND  -- 
4  100  --  --  17.3 4-  3.3  ND  -- 
4  --  --  10  14.7 4-  3.0  16.3 4- 2.5  1.1 
4  --  --  100  16.8 4- 2.0  20.6 4- 4.6  1.2 
--  --  40  --  1.2 4- 0.5  28.9 4- 5.8  24 
--  --  40  100  1.5 4-  1.1  30.2 4- 3.1  20 
--  100  40  --  1.0 4- 0.3  27.0 4- 5.1  27 
--  100  --  --  0.1  +  0.2  ND  -- 
--  --  --  100  0  0.2  4-  0.3 
Normal marrow cells and marrow  cells from mice 1 d  after an injection of 3  mg of FU were either 
assayed for CFU-S alone or when mixed with irradiated (20 Gy) marrow cells. Cells were irradiated 
in vitro and mixed with unirradiated cells within 30 min of the time of injection into lethally irradiated 
(9.5 Gy) hosts. Data are the means of at least  10 spleens per point.  ND, not done. 
at 14 d. This then raised the question of whether or not additional marrow cells 
in a  transplant influenced the lodging and/or subsequent growth of the injected 
CFU-S. To answer this question we mixed graded numbers of (a) irradiated (20 
Gy) normal marrow cells and (b) irradiated  1FU marrow cells with both unirra- 
diated normal marrow cells and unirradiated  1 FU cells, and assayed them at 8 
and 13 d. The irradiated cells were exposed to the 137Cs source in vitro no more 
than  30  min  before  they were  mixed  with  untreated  cells  and  injected.  The 
results in  Table  IV  show that the inclusion of as  many as  1  ×  106  irradiated 
marrow cells from either normal or FU-treated donors did not alter the number 
of spleen colonies formed by the nonirradiated cells, nor did they significantly 
alter the AI. These results suggest that, at least over the cell concentrations used, VAN  ZANT 
TABLE  V 
Atavism Index of Regenerating Marrow 
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Percent 
of CFU-  Atavism  Marrow cell donors  8 d colonies  14 d colonies  S in S  index 
Phase 
Not treated with hydroxyurea 
Given 50 mg of hydroxyurea 1 h before sac- 
rifice 
5.6 +  1.1  --  5.4 +  1.3  0.96 
2.8 +  0.8  50  3.0 -4- 0.5  1.07 
12 BDF~ mice were given 10 Gy of gamma irradiation and immediately injected intravenously with 
8 ×  l0  b syngeneic marrow cells. 7 d later, half the mice were injected with 50 mg i.v. of hydroxyurea; 
the other half were injected with saline. 1 h after those injections, femoral marrow was pooled from 
the two sets of donors and 1 ×  105 cells were injected into groups of 24 lethally irradiated hosts (10 
Gy). Spleens were harvested at 8 and 14 d and spleen colonies were counted after the spleens were 
fixed in Bouins' solution. 
spleen colony formation was unaffected by the presence of other normal or 1FU 
marrow cells. 
Rapidly Proliferating  CFU-S Don't Represent  a Primitive  CFU-S Subset.  To test 
the hypothesis that proliferating CFU-S represent a subset of the normal popu- 
lation with regard to spleen colony formation, we determined the fraction of 
CFU-S that synthesize DNA in marrow undergoing repopulation after sublethal 
irradiation and the AI of those cells (Table V).  50%  of the CFU-S from these 
marrow donors were killed by a  1-h exposure to hydroxyurea, indicating that 
most, if not all, were rapidly proliferating. The AI of this CFU-S population and 
of that population surviving hydroxyurea were both -1. These results suggest 
that rapidly proliferating CFU-S contain the same mix of subpopulations found 
in  normal  marrow and that  proliferative activity per se is  not an  identifying 
characteristic of either primitive CFU-S subsets or those with restricted devel- 
opmental potential. 
Discussion 
Our results corroborate the findings of Reissmann et al.  (17,  18),  Hodgson 
and Bradley (4), and Rosendaal et al. (5-7) and extend their observations on the 
toxicity of FU to  hematopoietic stem cells (CFU-S).  We show that FU,  either 
given in vivo or added to bone marrow cells in vitro, (a) caused a dose- and time- 
dependent depletion of the CFU-S population and, more importantly, (b) spared 
CFU-S that were qualitatively different from CFU-S in untreated marrow in that 
they resulted in spleen colonies that arose later than the colonies usually counted 
on days 8 or 9. We found that during a recovery period of -7 d  after FU the 
CFU-S  population  reassumed  the  properties  of the  normal  population;  i.e., 
colonies formed by these cells did not change in number between days 8 and 14 
of assay.  Moreover, during the 7-d postinjection period they rebounded to at 
least a fourfold higher frequency than in normal marrow. In contrast, the CFU- 
S population, shortly after FU exposure, especially during the first 2 d, formed 
few 8-d colonies but often formed a  20-fold greater number of 14-d colonies. 
The AI thus decreased steadily after FU to a normal value of 1 in ~7 d. 
I interpret these changes in the CFU-S population as follows. Spleen colony- 686  PRIMITIVE  HEMATOPOIETIC CELLS SPARED BY  5-FLUOROURACIL 
forming cells are a  heterogeneous population with different subsets giving rise 
to colonies at different times after transplantation. Those colonies arising early, 
at ~8 d, are derived from 'older' (in terms of mitotic history) or more differen- 
tiated stem cells, whereas 'younger', or more primitive stem cells, are responsible 
for colonies arising later, closer to  14 d after transplantation. FU is toxic to the 
subpopulation forming colonies early after transplantation but is relatively less 
toxic to cells forming late-appearing colonies. Therefore, immediately after FU 
injection the AI  is high because of the selective loss  of day 8  colony-formers. 
During  the  next  7  d,  the  normal  mix  of CFU-S  subpopulations,  older and 
younger,  is  restored.  The  older  subpopulations  ablated  by  FU  recover  via 
proliferation and differentiation of the surviving younger stem cells and at least 
part of this process must occur in the bone marrow rather than in the spleen. 
I have adopted the operational term 'atavism index' (AI) for the ratio of day 
14/day  8  colonies because of our results  and previous  findings showing that 
CFU-S surviving FU  have a  greater self-replicative capacity and repopulating 
ability than CFU-S in normal marrow (4-7).  When spleen colonies formed by 
FU-treated  marrow  were excised and  assayed for  CFU-S  in  a  second  set  of 
irradiated hosts,  substantially more spleen colonies formed than  from cells in 
spleen colonies derived from normal marrow. Moreover, many more progenitors 
of granulocytes, macrophages, and megakaryocytes were generated in lethally 
irradiated mice when they were injected with  FU-treated marrow than  when 
injected with normal  marrow. Thus it appears  that the CFU-S spared by FU 
have significantly greater developmental potential than the normal population 
and therefore represents a more primitive stem cell population. Hence the term 
'atavism index'. 
The greater developmental potential of CFU-S after FU argues (a) in favor of 
selective survival of a primitive CFU-S subpopulation(s) after FU and (b) against 
the possibility that the increase between days 8 and 14 in spleen colonies arising 
from  FU-treated  cells  simply  represents a  lag  period  during  which  sublethal 
damage caused by FU was repaired in a homogeneous population.  If the latter 
were the case the developmental characteristics of the CFU-S population would 
not be expected a priori to change as a function of repair. 
The cellular composition of spleen colonies arising from transplanted normal 
marrow has been shown to change with time of growth in the spleen even though 
the overall numbers do not (10,  11).  Colonies appearing at 8 d  or earlier were 
found to be predominately erythroid and often transient (11,  12).  Magli et al. 
(12) found that most of the colonies evident at days 10 or 12 were not visible at 
days 7 or 8 and that these late-appearing colonies, unlike the earlier, transient 
colonies, contained primitive cells able to  form multilineage colonies in  vitro. 
Therefore, they proposed that the cells giving rise to the early, mostly erythroid 
colonies were not  multipotential and were perhaps  analogous to  the BFU-E, 
which, in the same time period in vitro, form erythroid bursts. We believe that 
cells causing the growth of in  vivo colonies that appear after day 8  probably 
represent the true stem cells and that it is the most primitive subpopulation of 
those that is spared by FU. The in vitro correlates of cells forming spleen colonies 
after 8  d  may be  the CFU-GEMM  (granulocyte, erythroid, macrophage, and 
megakaryocytic CFU)  (18).  Both  cells are  multipotential  and  are  capable  of VAN  ZANT  687 
extensive proliferation but at present their mutual identity has not been proven. 
A significant result of the present studies is the finding that transplanted CFU- 
S  from  FU-treated  marrow,  but  not  from  normal  marrow,  must  make  an 
obligatory stopover in the bone marrow of hosts before spleen colonization and 
growth. When we injected FU marrow into irradiated hosts treated 7 d previously 
with 89Sr, we found that  they formed the usual,  small  number of 8-d spleen 
colonies. However, on day 14 when in normal hosts there was a  13-fold increase 
in spleen colonies, we found no significant change in the number of colonies in 
89Sr-containing hosts; CFU-S from untreated mice formed nearly identical num- 
bers of spleen colonies in both sets of hosts.  Klassen et al.  (16) found that the 
dose of radiation to the spleens of mice injected with 6 ~Ci/gm body weight of 
89Sr was <0.03 Gy per day after the first postinjection week. This low dose did 
not impair splenic hematopoiesis; in  fact, the spleen became the sole hemato- 
poietic organ in agSr-treated mice. We used a smaller dose of 2 ttCi of agSr/gm 
body weight in  the studies reported here.  Our findings provide experimental 
evidence consistent with the notion that the primitive CFU-S subset spared by 
FU seeds first in the marrow where it undergoes developmental maturation, and 
perhaps amplification, before spleen colonization. Furthermore, these data sug- 
gest that the marrow provides a microenvironment conducive to these develop- 
ment  steps  whereas  the  spleen  does  not.  Primitive  stem  cells  may seed  into 
'niches'  (I9)  or  'stem cell  regulatory domains'  (20)  present  only in  the bone 
marrow, whereas 'older' stem cells with diminished proliferative capacity lodge 
in niches or domains present in both the bone marrow and the spleen. In the 
adult animal, the reservoir of young stem cells may be restricted to the bone 
marrow. 
Recent studies have shown that the capacity of the stem cell compartment to 
restore hematopoiesis in irradiated mice is not compromised either during aging 
of the animal (21) or after 'aging' simulated by repetitive rounds of proliferation 
caused by repeated hydroxyurea injections (8).  In fact, in both studies, old stem 
cells were more effective than young stem cells in restoring hematopoiesis. Earlier 
results showing that the repopulating capacity of the stem cell compartment was 
limited (22) were based on serial transplantation of cells through irradiated hosts. 
The method of serial transplantation itself was recently shown to cause dimin- 
ished proliferative capacity rather than the 'aging' caused by repetitive repopu- 
lation (23). 
In contrast with our results implicating the marrow in stem cell maturation, 
Rosendaal et al. (5) concluded that colonies arising between 8 and 14 d were due 
to cells originally seeding in the spleen, but not immediately commencing growth. 
This conclusion was reached from studies in which they exteriorized and selec- 
tively irradiated (8.5  Gy) the spleens of hosts that  1 d  previously had received 
8.5 Gy of whole-body irradiation and an inoculum of FU-treated marrow. They 
found that 4 of the expected 22 colonies had subsequently developed by day 11 
in these mice. One possibility to account for the discrepancy between our two 
sets  of results is  that  the  18  'missing'  colonies were due  to  CFU-S  that  had 
migrated  from  the  marrow  in  the  24  h  between  cell  injection  and  spleen 
irradiation. The fact that there were any colonies at all in the doubly irradiated 
spleens  indicates  that  either the  spleens  were seeded from a  nonsplenic  site, 688  PRIMITIVE  HEMATOPOIETIC  CELLS  SPARED  BY  5-FLUOROURACIL 
possibly the marrow, or, as seems very unlikely, that CFU-S within the spleens 
survived a dose of 8.5 Gy of ionizing radiation. In our studies, a dose of 20 Gy 
killed all CFU-S in normal and FU-treated marrow (Table IV).  Unfortunately, 
these authors  did  not  include any times  in  addition  to  the  11-d  assay point, 
making it difficult to assess the effect on the AI of reirradiating the spleens. 
FU is toxic to cells synthesizing DNA, thus raising the possibility that prolif- 
erative quiescent stem cells, those static in G~ (or Go) and possibly spared by FU, 
may represent the source of spleen colonies arising between days 8 and 14. We 
have shown, however, that proliferating CFU-S do not represent a subpopulation 
with  intrinsically  different  growth  patterns  in  the  spleen  than  the  normal, 
quiescent  CFU-S  population  (Table  V).  Marrow  regenerating after  sublethal 
irradiation contained a  rapidly proliferating CFU-S population  of which 50% 
were in  S  phase.  Both  this  population  and that  remaining after the selective 
killing of cells synthesizing DNA had an AI close to 1. This is consistent with the 
findings of Ross et al. (8) showing that the proportion of cycling CFU-S does not 
necessarily reflect the proportion of the CFU-S subset with elevated proliferative 
capacity. 
Summary 
Mouse marrow cells were exposed to 5-fluorouracil (FU) either in vivo or in 
vitro and the effects on the hematopoietic stem cell compartment were studied. 
The drug was highly toxic to bone marrow cells including the spleen colony- 
forming unit (CFU-S) population. The small population of stem cells surviving 
FU, however, caused a different pattern of spleen colony growth when injected 
into  lethally irradiated  mice.  Whereas  numbers of spleen  colonies caused by 
normal marrow cells remained constant during an 8-14 d period after transplan- 
tation,  spleen colonies derived from FU-treated marrow cells increased by as 
much as 100-fold during this time. This effect on stem cells was dose dependent 
both in vitro and in vivo. When FU was given in vivo, the day 14/day 8 ratio of 
colonies was greatest  1 d  after injection and, over the next 7 d, returned to a 
near-normal value, that is, unity. 
A number of studies have shown that the stem cell compartment is heteroge- 
neous with respect to self-replicative capacity and developmental potential. An 
age structure for the stem cell compartment has been proposed wherein cells 
with a  short mitotic history are more likely to  self-replicate than  they are to 
differentiate; hence they are more primitive.  'Older'  stem cells with a  longer 
mitotic history are, according to the hypothesis, more likely to differentiate. 5- 
fluorouracil may be toxic to the older stem cells and selectively spare the more 
primitive subpopulation.  Although the  surviving cells may not themselves be 
able to form spleen colonies, they may give rise to an older cohort of cells more 
likely to differentiate and form spleen colonies. It is the requisite developmental 
maturation within the stem cell compartment that may be responsible for the 
delay in appearance of spleen colonies derived from FU-treated marrow. Our 
results support  this  explanation and identify the locus of at  least part of this 
activity as the bone  marrow.  We  found that  the  FU-treated marrow did not 
cause an increase in spleen colony numbers between 8 and 14 d  in hosts with a 
long-standing marrow aplasia, due to the incorporation of 89Sr into bone. VAN  ZANT  689 
I propose that the delayed spleen colony appearance in normal hosts is the 
result of developmental maturation of the primitive stem cell compartment that 
survives FU and is responsible for spleen colonies arising around day  14.  This 
maturation, at least initially, occurs in the marrow and leads to the replenishment 
of the  more differentiated CFU-S  subsets  ablated  by FU,  which are  normally 
responsible for spleen colonies appearing earlier after transplantation. 
I am grateful to C. Glenn Fry and Kathy McDonald for expert technical and secretarial 
assistance, respectively. 
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